C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population

Stroke

Volumn 31, Issue 4, 2000, Pages 936-939

  Ito, Daisuke ^a   Murata, Mitsuru ^a   Watanabe, Kiyoaki ^a   Yoshida, Tadashi ^a   Saito, Ikuo ^a   Tanahashi, Norio ^a   Fukuuchi, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cerebrovascular disorders; Oxygen radical; Polymorphism (genetics); Risk factors; Stroke, ischemic

Indexed keywords

OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

EID: 0343527886     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.4.936     Document Type: Article

References (17)

1. Liu TH, Beckman HS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol. 1989;256:H589-H593.
2. Imaizumi S, Woolworht V, Fishman RA, Chan PH. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke. 1990;21:1312-1317.
3. He YY, HSU CY, Ezrin AM, Miller MS. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia reperfusion. Am J Physiol. 1993;265:H252-H256.
4. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27: 1124-1129.
5. Del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlusion and reperfusion in baboon. Stroke. 1991;22:1276-1283.
6. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke. 1997;8:2252-2258.
7. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
8. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
9. Harrison DG. Endothelial function and oxidant stress. Clin Cordiol. 1997;20:II-11-II-17.
10. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;38: 23317-23321.
11. Babior BM. NADPH oxidase: an update. Blood. 1999 93;1464-1476.
12. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH. Human neutrophil cytochromc b light chain (p22-phox). Gene structure, chromosomal location, and mutation in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86: 1729-1737.
13. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 1998;97:135-137.
14. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis. 1999;145:315-323.
15. Li A, Prasad A, Mincemoyer R, Satorius C, Epstein N, Finkel T, Quyyumi AA. Relationship of the C242T P22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet. 1999;86:57-61.
16. Cai H, Duarte N, Wilcken DE, Wang XL. NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest. 1999;29:744-788.
17. Ad Hoc Committee of National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Disease III. Stroke. 1990;21: 637-676.